Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001615774-18-006278
Filing Date
2018-07-06
Accepted
2018-07-06 17:03:56
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5. s111202_424b5.htm 424B5 437690
2 GRAPHIC s111202_logo.jpg GRAPHIC 17889
  Complete submission text file 0001615774-18-006278.txt   463579
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 424B5 | Act: 33 | File No.: 333-207600 | Film No.: 18942964
SIC: 8731 Services-Commercial Physical & Biological Research